When is recombinant luteinizing hormone supplementation beneficial during ovarian stimulation?
A successful outcome for assisted reproductive technologies (ART) is greatly influenced by optimal ovarian stimulation. In the unstimulated cycle, follicle stimulating hormone (FSH) and luteinizing hormone (LH) play a synergistic role in steroid production and folliculogenesis. Exposure of the theca cells to LH leads to production of androstenedione, an essential substrate for its conversion to estradiol by granulosa cells. In contrast, in cycles where exogenous gonadotropins are employed, the requirement and role for LH is controversial, including the role of recombinant LH (rLH).
Source: fertstert.org
When is recombinant luteinizing hormone supplementation beneficial during ovarian stimulation?
Published in Embryology and Reproductive Medicine
More from Embryology and Reproductive MedicineMore posts in Embryology and Reproductive Medicine »
- Life after Stillbirth
- The possible impact of COVID 19 on fertility and ART
- Human embryonic stem cell–derived blastocyst-like spheroids resemble human trophectoderm during early implantation process
- What support is available for you in hospital if you lose your baby
- Estrogen receptor-α immunoreactivity predicts symptom severity and pain recurrence in deep endometriosis
Be First to Comment